Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Eur Urol. 2015 Apr;67(4):637-45. doi: 10.1016/j.eururo.2014.10.028. Epub 2014 Oct 31.
The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.
To systematically review the literature on quality of life (QoL) in patients undergoing AS.
Embase, Medline, Psychinfo, Cochrane Central, Web of Science, and PubMed databases were searched in May 2014 using quality of life, active surveillance, prostate cancer, their synonyms, and targeted manual searches. The psychological dimensions related to health-related QoL (HRQoL) outcomes were anxiety and depression, distress, decisional conflict, and mental health.
Ten clinical and research-based AS studies worldwide measured HRQoL and related psychological facets in six cross-sectional studies and four cohorts (follow-up: 9-36 mo; published: 2006-2014). Six studies were linked to published AS cohorts. In total, 966 men undergoing AS (mean: 102 per study) were assessed (mean age: 66 yr). AS patients had good overall HRQoL scores, which were comparable or better than those of patients undergoing postradical treatment (comparator group in four studies), men's partners (one study) and population-based data (three studies). Anxiety and depression scores were favourable. Selection bias may be present, as none were randomised comparisons. Decreased psychological well-being may be partly predicted by AS patients' baseline and clinical characteristics.
Patients undergoing AS reported good QoL and did not appear to suffer major negative psychological impacts. Longer follow-up is required as well as investigation into which patients are predisposed to negative impact and leaving AS prematurely.
We reviewed the published evidence for quality-of-life impact on men with prostate cancer being monitored by active surveillance. The men who were on active surveillance usually reported good levels of well-being and did not appear to suffer major negative psychological impacts. The research findings suggest little presence of anxiety and depression and high overall quality of life related to their disease. However, there are few long-term studies, so more high-quality research is needed to make definitive recommendations.
局部筛查前列腺癌的最佳治疗方法仍存在争议,这与筛查的过度治疗问题和非随机的循证医学基础有关。主动监测(AS)旨在延迟或避免根治性治疗,但通过不治疗前列腺癌,可能会对患者的健康造成潜在危害。
系统地回顾有关接受 AS 治疗的患者生活质量(QoL)的文献。
2014 年 5 月,通过 Embase、Medline、Psychinfo、Cochrane Central、Web of Science 和 PubMed 数据库,使用生活质量、主动监测、前列腺癌及其同义词进行了检索,并进行了有针对性的手工检索。与健康相关的 QoL(HRQoL)结果相关的心理维度包括焦虑和抑郁、痛苦、决策冲突和心理健康。
全球有 10 项基于临床和研究的 AS 研究,在 6 项横断面研究和 4 项队列研究(随访:9-36 个月;发表时间:2006-2014 年)中测量了 HRQoL 和相关心理方面。有 6 项研究与已发表的 AS 队列相关。总共评估了 966 名接受 AS(平均每个研究 102 名)的男性(平均年龄:66 岁)。AS 患者的整体 HRQoL 评分较好,与接受根治性治疗(四项研究中的对照组)、患者的伴侣(一项研究)和人群数据(三项研究)的评分相当或更好。焦虑和抑郁评分良好。可能存在选择偏倚,因为没有随机比较。AS 患者的基线和临床特征可能部分预测心理幸福感下降。
接受 AS 的患者报告生活质量良好,似乎没有受到重大的负面影响。需要进行更长时间的随访,以及研究哪些患者更容易受到负面影响并提前退出 AS。
我们回顾了发表的关于通过主动监测监测前列腺癌的男性生活质量影响的证据。接受主动监测的男性通常报告了良好的健康水平,似乎没有受到重大的负面影响。研究结果表明,与疾病相关的焦虑和抑郁程度较低,整体生活质量较高。然而,长期研究较少,因此需要更多高质量的研究来做出明确的建议。